Advocacy at a Glance STEVEN GROSSMAN 9/27/13 Advocacy at a Glance STEVEN GROSSMAN 9/27/13 Latest on the Continuing Resolution and more Read More Uncategorized STEVEN GROSSMAN 9/13/13 Uncategorized STEVEN GROSSMAN 9/13/13 The FY 14 CR Circulated in the House This Week Read More Advocacy at a Glance STEVEN GROSSMAN 9/13/13 Advocacy at a Glance STEVEN GROSSMAN 9/13/13 Regulatory Science Featured at NCTR Conference in Arkansas; Highlighted by Commissioner and more Read More Advocacy at a Glance STEVEN GROSSMAN 9/6/13 Advocacy at a Glance STEVEN GROSSMAN 9/6/13 Congress Returns to Washington on Tuesday, Deadline for Government Funding Looms and more Read More Uncategorized STEVEN GROSSMAN 9/6/13 Uncategorized STEVEN GROSSMAN 9/6/13 Implications of the August 20 OMB Report Read More Uncategorized STEVEN GROSSMAN 8/23/13 Uncategorized STEVEN GROSSMAN 8/23/13 At CDER and CBER ... Three Positives and Three Concerns Read More Advocacy at a Glance STEVEN GROSSMAN 8/23/13 Advocacy at a Glance STEVEN GROSSMAN 8/23/13 Boehner Proposes "Short-Term" Spending Bill to Avert Government Shutdown and more Read More Uncategorized STEVEN GROSSMAN 8/16/13 Uncategorized STEVEN GROSSMAN 8/16/13 The Alliance Succeeds Because of Its Members' Help and Support Read More Advocacy at a Glance STEVEN GROSSMAN 8/16/13 Advocacy at a Glance STEVEN GROSSMAN 8/16/13 Alliance Meets with Key Leaders of FDA’s International Programs and more Read More Uncategorized STEVEN GROSSMAN 8/9/13 Uncategorized STEVEN GROSSMAN 8/9/13 Three Choices for FDA Budget for FY 14 ... Maybe Read More Uncategorized STEVEN GROSSMAN 8/9/13 Uncategorized STEVEN GROSSMAN 8/9/13 R&D Reclassified from Expense to Investment and more Read More Uncategorized STEVEN GROSSMAN 8/2/13 Uncategorized STEVEN GROSSMAN 8/2/13 Congress Leaves ... With No Clear Pathway Ahead Read More Uncategorized STEVEN GROSSMAN 8/2/13 Uncategorized STEVEN GROSSMAN 8/2/13 Sequestration as Government Malpractice: Op Ed and more Read More Uncategorized STEVEN GROSSMAN 7/26/13 Uncategorized STEVEN GROSSMAN 7/26/13 The GIGO Effect, FDA's Budget, and FDA Spending Read More Advocacy at a Glance STEVEN GROSSMAN 7/26/13 Advocacy at a Glance STEVEN GROSSMAN 7/26/13 FDA-Regulated Industries are a Backbone of the U.S. Economy and more Read More Uncategorized STEVEN GROSSMAN 7/19/13 Uncategorized STEVEN GROSSMAN 7/19/13 FY 14, Sequestration, and the Eshoo Initiative Read More Advocacy at a Glance STEVEN GROSSMAN 7/19/13 Advocacy at a Glance STEVEN GROSSMAN 7/19/13 Representative Eshoo Introduces User Fee Sequester Legislation Read More Uncategorized STEVEN GROSSMAN 7/12/13 Uncategorized STEVEN GROSSMAN 7/12/13 Time for a Review of the FY 14 Budget Status Read More Uncategorized STEVEN GROSSMAN 7/12/13 Uncategorized STEVEN GROSSMAN 7/12/13 Stripped-down Farm Bill Passes House and more Read More Advocacy at a Glance STEVEN GROSSMAN 6/28/13 Advocacy at a Glance STEVEN GROSSMAN 6/28/13 Why the Farm Bill May Impact the FDA Budget Read More Newer Posts Older Posts
Advocacy at a Glance STEVEN GROSSMAN 9/27/13 Advocacy at a Glance STEVEN GROSSMAN 9/27/13 Latest on the Continuing Resolution and more Read More
Uncategorized STEVEN GROSSMAN 9/13/13 Uncategorized STEVEN GROSSMAN 9/13/13 The FY 14 CR Circulated in the House This Week Read More
Advocacy at a Glance STEVEN GROSSMAN 9/13/13 Advocacy at a Glance STEVEN GROSSMAN 9/13/13 Regulatory Science Featured at NCTR Conference in Arkansas; Highlighted by Commissioner and more Read More
Advocacy at a Glance STEVEN GROSSMAN 9/6/13 Advocacy at a Glance STEVEN GROSSMAN 9/6/13 Congress Returns to Washington on Tuesday, Deadline for Government Funding Looms and more Read More
Uncategorized STEVEN GROSSMAN 9/6/13 Uncategorized STEVEN GROSSMAN 9/6/13 Implications of the August 20 OMB Report Read More
Uncategorized STEVEN GROSSMAN 8/23/13 Uncategorized STEVEN GROSSMAN 8/23/13 At CDER and CBER ... Three Positives and Three Concerns Read More
Advocacy at a Glance STEVEN GROSSMAN 8/23/13 Advocacy at a Glance STEVEN GROSSMAN 8/23/13 Boehner Proposes "Short-Term" Spending Bill to Avert Government Shutdown and more Read More
Uncategorized STEVEN GROSSMAN 8/16/13 Uncategorized STEVEN GROSSMAN 8/16/13 The Alliance Succeeds Because of Its Members' Help and Support Read More
Advocacy at a Glance STEVEN GROSSMAN 8/16/13 Advocacy at a Glance STEVEN GROSSMAN 8/16/13 Alliance Meets with Key Leaders of FDA’s International Programs and more Read More
Uncategorized STEVEN GROSSMAN 8/9/13 Uncategorized STEVEN GROSSMAN 8/9/13 Three Choices for FDA Budget for FY 14 ... Maybe Read More
Uncategorized STEVEN GROSSMAN 8/9/13 Uncategorized STEVEN GROSSMAN 8/9/13 R&D Reclassified from Expense to Investment and more Read More
Uncategorized STEVEN GROSSMAN 8/2/13 Uncategorized STEVEN GROSSMAN 8/2/13 Congress Leaves ... With No Clear Pathway Ahead Read More
Uncategorized STEVEN GROSSMAN 8/2/13 Uncategorized STEVEN GROSSMAN 8/2/13 Sequestration as Government Malpractice: Op Ed and more Read More
Uncategorized STEVEN GROSSMAN 7/26/13 Uncategorized STEVEN GROSSMAN 7/26/13 The GIGO Effect, FDA's Budget, and FDA Spending Read More
Advocacy at a Glance STEVEN GROSSMAN 7/26/13 Advocacy at a Glance STEVEN GROSSMAN 7/26/13 FDA-Regulated Industries are a Backbone of the U.S. Economy and more Read More
Uncategorized STEVEN GROSSMAN 7/19/13 Uncategorized STEVEN GROSSMAN 7/19/13 FY 14, Sequestration, and the Eshoo Initiative Read More
Advocacy at a Glance STEVEN GROSSMAN 7/19/13 Advocacy at a Glance STEVEN GROSSMAN 7/19/13 Representative Eshoo Introduces User Fee Sequester Legislation Read More
Uncategorized STEVEN GROSSMAN 7/12/13 Uncategorized STEVEN GROSSMAN 7/12/13 Time for a Review of the FY 14 Budget Status Read More
Uncategorized STEVEN GROSSMAN 7/12/13 Uncategorized STEVEN GROSSMAN 7/12/13 Stripped-down Farm Bill Passes House and more Read More
Advocacy at a Glance STEVEN GROSSMAN 6/28/13 Advocacy at a Glance STEVEN GROSSMAN 6/28/13 Why the Farm Bill May Impact the FDA Budget Read More
